Molecular Neurobiology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of IJMS focuses on publishing high-quality manuscripts that report on a broad range of topics of general interest to those working in the field of molecular neurobiology. Topics include, but are not limited to, the following:
- Neurobiology
- Neurochemistry
- Neurology
- Neuropathology
- Neurophysiology
- Neuropharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Understanding the Impacts of Neurodevelopmental Cannabinoid Exposure (Deadline: 31 May 2022)
- Stress-Related Disorders and Depression: From Molecular Basis to Therapy (Deadline: 31 May 2022)
- The Neurobiology of Substance Addiction (Deadline: 31 May 2022)
- Molecular Mechanisms of Neuropathic Pain and Nerve Injury (Deadline: 31 May 2022)
- Advance in Research on Neurogenesis (Deadline: 31 May 2022)
- Molecular Mechanisms and Pathophysiology of Cerebral Ischemia (Deadline: 31 May 2022)
- Molecular Mechanisms, Pathophysiology and Phenotypes of Mitochondrial Disorders (Deadline: 31 May 2022)
- Neurobiology of Aging and Aging-Related Disorders (Deadline: 31 May 2022)
- The Molecular Brain and Its Health (Deadline: 31 May 2022)
- Role of Astrocytes in Neurological Diseases (Deadline: 31 May 2022)
- Neuro–Immune Interactions in Health and Disease (Deadline: 31 May 2022)
- Connecting In Vitro, In Vivo, and Ex Vivo Studies in Neurodegenerative Diseases (Deadline: 31 May 2022)
- Role of Extracellular Matrix Molecules in CNS Injury, Aging and Neurodegenerative Disease (Deadline: 31 May 2022)
- Development of New Drugs against Stroke (Deadline: 31 May 2022)
- Neurodegenerative Diseases: From Molecular Basis to Therapy (Deadline: 31 May 2022)
- Towards an Understanding of Retinal Diseases and Novel Treatment 2.0 (Deadline: 31 May 2022)
- Disease Modifying Translational Research for Neurological Disorders and Brain Damages (Deadline: 31 May 2022)
- Neurofibromatosis: Study of Molecular Mechanisms (Deadline: 31 May 2022)
- Frontiers in Glioma Pathobiology (Deadline: 31 May 2022)
- Neuroendocrine Factors in Health and Disease (Deadline: 31 May 2022)
- Neurolipids in Neurodegenerative Disorders (Deadline: 31 May 2022)
- Biological Functions of Neurotrophins: New Insights from Canonical and Noncanonical Model Organisms (Deadline: 31 May 2022)
- Frontiers in Molecular Mechanisms of Stroke (Deadline: 31 May 2022)
- Neurogenesis and Neural Plasticity 2.0 (Deadline: 31 May 2022)
- Neurotoxins in the Neurosciences: Molecular Mechanisms and Applications 2.0 (Deadline: 31 May 2022)
- Glioma: Molecular Aspects and Theranostics (Deadline: 31 May 2022)
- Brain/Mind Activity and Molecular Dynamics in Biological Systems (Deadline: 15 June 2022)
- Alzheimer's disease: From Molecular Basis to Therapy (Deadline: 15 June 2022)
- Retinal Degeneration and Protection (Deadline: 24 June 2022)
- Astrocyte–Neuron Communication in Neurological Disorders (Deadline: 25 June 2022)
- Synaptic Plasticity and Diseases (Deadline: 30 June 2022)
- Sodium Voltage-Operated Neural Channel Modulators in Peripheral Nervous System Disorders (Deadline: 30 June 2022)
- Cellular and Molecular Mechanisms in Neurodevelopmental Disorders and Brain Tumors (Deadline: 30 June 2022)
- State-of-the-Art Molecular Neurobiology in Chile (Deadline: 30 June 2022)
- New Advances in Research on Alzheimer's Disease (Deadline: 30 June 2022)
- Peripheral Biomarkers in Neurodegenerative Diseases 3.0 (Deadline: 30 June 2022)
- Molecular Mechanisms of Aging-Related Neurodegenerative Diseases (Deadline: 30 June 2022)
- Newly Developed Drugs for Alzheimer's Disease (Deadline: 30 June 2022)
- Advances in the Research of Neural Circuits (Deadline: 30 June 2022)
- The Pathogenesis and Therapeutic Strategies for Understanding and Treating Diabetic Neuropathy of the Retina (Deadline: 30 June 2022)
Non-Coding RNAs in Human Neurodevelopmental Disorders and Brain Disorders
(Deadline: 30 June 2022)- Brain Neurotransmitters in Genetic Control of Behavior 2.0 (Deadline: 30 June 2022)
- Inflammation in Neurodegeneration (Deadline: 30 June 2022)
- Disorders of Cholesterol Homeostasis (Deadline: 30 June 2022)
- Alterations of Cell-to-Cell Communication in the Aging Brain and in Neurological Diseases (Deadline: 30 June 2022)
- Lipids in Neurodegenerative Disorders (Deadline: 30 June 2022)
- Recent Advances on Mitochondrial Diseases (Deadline: 30 June 2022)
- Exosome: New Approaches of Therapy for Neurodegenerative Diseases (Deadline: 30 June 2022)
- Advances in Neurodevelopmental Disorders (NDDs) Research (Deadline: 30 June 2022)
- Cerebellar Ataxia (Deadline: 30 June 2022)
- Synaptic Vulnerability: From Biological to Therapeutic Point of View (Deadline: 30 June 2022)
- Advances in Stress and Depression Research: Neurobiology, Models, Biomarkers and Therapies (Deadline: 30 June 2022)
- Proteinopathies in Frontotemporal Lobar Degeneration (Deadline: 30 June 2022)
- Advances in Neurodegenerative Diseases Research and Therapy (Deadline: 30 June 2022)
- Molecular Mechanisms of Neural Circuit Development and Regeneration 2.0 (Deadline: 30 June 2022)
- Development of Dopaminergic Neurons (Deadline: 30 June 2022)
- Neuroinflammation in Parkinson's Disease (Deadline: 30 June 2022)
- Cellular Mechanisms in Neuropathic Pain (Deadline: 30 June 2022)
- Epigenetic Age Acceleration in Neurodevelopmental and Cognitive Disorders (Deadline: 30 June 2022)
- Molecular Mechanisms of Neuronal Death in Neurodegeneration (Deadline: 30 June 2022)
- Neuropathology and Cellular Mechanisms in Traumatic Brain Injury (Deadline: 30 July 2022)
- Neuroinflammation: From Molecular Mechanisms to Therapeutic Perspectives (Deadline: 30 July 2022)
- Molecular Advances in Schizophrenia (Deadline: 31 July 2022)
- Molecular Mechanisms of Addictive Disorders (Deadline: 31 July 2022)
- Mitochondrial Dynamics in Neurons (Deadline: 31 July 2022)
- Endovascular Treatment and Interventional Neurology (Deadline: 31 July 2022)
- New Molecular Insights into Neurocutaneous Syndromes (Deadline: 31 July 2022)
- Effect of Mesenchymal Stem Cells on Neurogenesis, Affective and Cognitive Behavior (Deadline: 31 July 2022)
- Frontier on Alzheimer's Disease (Deadline: 31 July 2022)
- Molecular and Cellular Mechanisms of Synchronization within the Mammalian Circadian System (Deadline: 31 July 2022)
- Molecular Research on Mental Disorders (Deadline: 31 July 2022)
- Spine and Spinal Cord Injury (Deadline: 31 July 2022)
- Modulation of Neuronal Excitability, Synaptic Transmission, and Plasticity in Health and Disease 2.0 (Deadline: 31 July 2022)
- Molecular Research on Amyotrophic Lateral Sclerosis (Deadline: 31 July 2022)
- The Role of Neurons in Human Health and Disease (Deadline: 31 July 2022)
- The Mechanisms Regulation of the Neuromuscular Dysfunctions (Deadline: 31 July 2022)
- Molecules Affecting Brain Development and Nervous System (Deadline: 31 July 2022)
- Regulation and Function of Neural Attributes: From Gene to Behavior (Deadline: 31 July 2022)
- The Role of Neuroimmune Inflammation in Chemotherapy-Induced Side Effects (Deadline: 31 July 2022)
- Drosophila Models for Neurodegenerative Diseases: Achievements and Prospects (Deadline: 31 July 2022)
- Neuronal Voltage-Gated Channel Regulation (Deadline: 15 August 2022)
- Responsible Factors for Neuromorphogenesis in the Brain (Deadline: 31 August 2022)
- Ribbon Synapses: Molecular Mechanisms of Synaptic Signaling and Involvement in Diseases (Deadline: 31 August 2022)
- Molecular Research on Neural Stem Cells in Physiological and Pathological Condition (Deadline: 31 August 2022)
- Genetic and Molecular Regulations of Neuronal Activity (Deadline: 31 August 2022)
- Kinase-Mediated Signaling in Mood Disorders (Deadline: 31 August 2022)
- Modeling Neurological Disorders in Experimental Animals: New Insights and Emerging Roles 2.0 (Deadline: 31 August 2022)
- Neural Dynamics and Regulation in Epilepsy (Deadline: 31 August 2022)
- Molecular Research on Rett Syndrome and Related Disorders 2.0 (Deadline: 31 August 2022)
- Gut-Brain Axis of Neurodegenerative Disease (Deadline: 31 August 2022)
- Molecular Research on Parkinson's Disease (Deadline: 31 August 2022)
- Roles of Glia in CNS: Toward the Development of New Antidepressant Strategies? (Deadline: 31 August 2022)
- Neurobiology of Vision in Health and Disease (Deadline: 31 August 2022)
- Immunology of Neuropsychiatric Disorders (Deadline: 31 August 2022)
- Oligodendrocytes and Neurovascular Unit (Deadline: 31 August 2022)
- Research of Neuronal Cell in Nervous System Development and Disease (Deadline: 31 August 2022)
- Autophagy in the Nervous System (Deadline: 31 August 2022)
- Glycome and Nervous System (Deadline: 31 August 2022)
- Advances in the Research of Acute Ischemic Stroke (Deadline: 31 August 2022)
- The Gut–Liver–Brain Axis: From Head to Feet (Deadline: 31 August 2022)
- Neuroinflammation: From Molecular Basis to Therapy (Deadline: 31 August 2022)
- Cell Signaling in Neurodegeneration 3.0 (Deadline: 31 August 2022)
- Intersection between Cognitive Impairment and Metabolic Alterations in the Molecular Mechanisms of Neurodegeneration (Deadline: 31 August 2022)
- Advances in Epilepsy and Headache (Deadline: 31 August 2022)
- Novel Therapeutic Approaches for Neural Repair (Deadline: 31 August 2022)
- Impact of Lipid Homeostasis in Neurodegenerative Diseases (Deadline: 15 September 2022)
- Proteomics in Diagnosis and Treatment of Neurodegenerative Diseases (Deadline: 22 September 2022)
- Prions and Prion Diseases 3.0 (Deadline: 25 September 2022)
- Molecular Researches on Ischemic Stroke (Deadline: 30 September 2022)
- mTOR Signaling in Inflammation, Brain Injuries and Neurodegeneration (Deadline: 30 September 2022)
- Molecular Regulators and Investigation of Neurodegeneration Diseases (Deadline: 30 September 2022)
- Epigenetic Mechanisms of Neurodegenerative Diseases (Deadline: 30 September 2022)
- Plasticity and Neurodegenerative Diseases (Deadline: 30 September 2022)
- Gender-Related Molecular Mechanism in Neurological Disorders (Deadline: 30 September 2022)
- Synucleins in Neurodegeneration (Deadline: 30 September 2022)
- Latest Advances in Neuroscience (Deadline: 30 September 2022)
- Molecular Mechanism of Natural Compounds in Neuroinflammation (Deadline: 30 September 2022)
- Biochemical and Molecular Adaptation to Neuromuscular Conditioning (Deadline: 30 September 2022)
- Applications of Mesenchymal Stem Cells in Neuroscience 2.0 (Deadline: 30 September 2022)
- GABAergic and Glycinergic Neurons (Deadline: 30 September 2022)
- Neurobiology of Protein Synuclein (Deadline: 30 September 2022)
- The Link between Stem Cells and Nervous System (Deadline: 30 September 2022)
- Neuropathic Pain Molecular Mechanism and Therapy (Deadline: 30 September 2022)
- Sexual Dimorphism in Neurological Diseases: From Molecular Basis to Therapy (Deadline: 30 September 2022)
- Neural Correlates and Molecular Mechanisms of Memory and Learning (Deadline: 30 September 2022)
- Molecular Pharmacology and Genomics in Psychiatry (Deadline: 30 September 2022)
- TDP-43 Biology and Pathology (Deadline: 30 September 2022)
- Neuro-Oncology: From Molecular Basis to Therapy (Deadline: 12 October 2022)
- Physiological or Pathological Molecular Alterations in Brain Aging 2.0 (Deadline: 15 October 2022)
- Updates on Neuroendocrine Research in Health and Disease (Deadline: 15 October 2022)
- Molecular Biomarkers in Neurodevelopmental and Neurodegenerative Disorders (Deadline: 20 October 2022)
- Molecular Research on Neurodegenerative Diseases 3.0 (Deadline: 25 October 2022)
- CNS Drug Action in Neurodegenerative Diseases 2.0 (Deadline: 30 October 2022)
- Molecular and Cellular Research on Optic Nerve Disease (Deadline: 31 October 2022)
- Neurogenetics in Neurology (Deadline: 31 October 2022)
- Neurometabolic Disorders in the Adults (Deadline: 31 October 2022)
- Molecular Research in Neuroimmunological Disorders (Deadline: 31 October 2022)
- Molecular Insights in Psychiatry 2.0 (Deadline: 31 October 2022)
- Alpha-Synuclein in Neurological Disorders: From Physiology to Pathology (Deadline: 31 October 2022)
- Neurodegenerative Diseases and Intellectual Disabilities: From Molecular Basis to Therapy (Deadline: 31 October 2022)
- Recent Advances in the Research of Mental Disorders (Deadline: 31 October 2022)
- The Role of Natural Products in the Treatment of Neuronal Disease (Deadline: 31 October 2022)
- Autoimmunity in the Nervous Systems: Multiple Sclerosis and Beyond 2.0 (Deadline: 31 October 2022)
- Brain-Body Bidirectional Communication and Its Relevance for Cerebrovascular Diseases (Deadline: 31 October 2022)
- Metabolic Influences on Neurodegeneration (Deadline: 31 October 2022)
- Cell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules 2.0 (Deadline: 31 October 2022)
- Neural and Vascular Dysfunctions in Retinal Diseases: Mechanisms and Treatments (Deadline: 31 October 2022)
- Alzheimer’s Disease Pathogenesis, Diagnostics, and Treatment in The Early Stages (Deadline: 31 October 2022)
- Recent Advances on Meningiomas (Deadline: 31 October 2022)
- Pathogenesis and Treatment Mechanisms of Depression (Deadline: 31 October 2022)
- The Multiple Mechanisms Underlying Neuropathic Pain (II) (Deadline: 31 October 2022)
- Pathogenesis of Diseases of the Central Nervous System (Deadline: 31 October 2022)
- Molecular Mechanisms of Neural Stem Cells (NSC) Development - Systems Approach (Deadline: 31 October 2022)
- Zebrafish Models in Toxicology and Disease Studies (Deadline: 31 October 2022)
- Biomarkers in Common and Rare Neurological Disorders (Deadline: 31 October 2022)
- Molecular Mechanism Underlying Rare Inherited Neurological Diseases (Deadline: 31 October 2022)
- Molecular and Cellular Neurobiology of Migraine (Deadline: 10 November 2022)
- Role and Dynamics of Extracellular Vesicles in Central Nervous System Diseases 2.0 (Deadline: 15 November 2022)
- Role of Dopamine in Health and Disease—Biological Aspect (Deadline: 15 November 2022)
- Beyond the Primary Infarction: Focus on Mechanisms Related to Secondary Neurodegeneration after Stroke 2022 (Deadline: 15 November 2022)
- Molecular Biomarkers in Neurological Diseases (Deadline: 15 November 2022)
- Neurolipids in Neurodegenerative Processes (Deadline: 30 November 2022)
- Molecular Mechanisms of Schizophrenia and Novel Targets 2.0 (Deadline: 30 November 2022)
- Brain Mechanisms of Sleep Related Disorders 2.0 (Deadline: 30 November 2022)
- Protein Aggregates Toxicity: New Insights into the Mechanisms 2.0 (Deadline: 30 November 2022)
- Molecular Mechanisms and Pathophysiology of Neuronal Aging (Deadline: 30 November 2022)
- Ischemic Brain Neurodegeneration 2.0 (Deadline: 30 November 2022)
- Molecular Pathogenesis of Alzheimer's Disease 2.0 (Deadline: 30 November 2022)
- Novel Concepts, New Perspectives, and Current Therapies for Parkinson's Disease (Deadline: 30 November 2022)
- Molecular Mechanisms of Synaptic Plasticity 3.0 (Deadline: 30 November 2022)
- Identifying the Molecular Mechanisms of Psychiatric Disorders to Define New Therapeutic Targets (Deadline: 30 November 2022)
- The Role of Cerebrospinal Fluid and Blood Biomarkers in Neurological Diseases (Deadline: 30 November 2022)
- Plasticity of the Nervous System after Injury (Deadline: 10 December 2022)
- Early Diagnosis and Monitoring of Neuroendocrine Tumours: State of the Art and Future Perspectives (Deadline: 10 December 2022)
- New Breakthrough in Alzheimer’s Pathogenesis (Deadline: 10 December 2022)
- Recent Progress in Multiple Sclerosis 2.0 (Deadline: 10 December 2022)
- Genomics of Brain Disorders 4.0 (Deadline: 15 December 2022)
- Molecular Research in Neuro-Urology (Deadline: 20 December 2022)
- Amyotrophic Lateral Sclerosis as a Systemic Disease (Deadline: 30 December 2022)
- Neurobiology of Parkinson’s Disease (Deadline: 31 December 2022)
- Neuron and Brain Maturation 2.0 (Deadline: 31 December 2022)
- Molecular Mechanisms and Therapies in Neurological Diseases 2022 (Deadline: 31 December 2022)
- Mitochondria as a Cellular Hub in Neurological Disorders (Deadline: 31 December 2022)
- Epigenetic Regulation in Neurodegeneration Disease 2.0 (Deadline: 31 December 2022)
- Neuropathological Advances in Brain Disorders from MNS2022 (Deadline: 31 December 2022)
- New Trends in Alzheimer's Disease Research: From Molecular Mechanisms to Therapeutics (Deadline: 31 January 2023)
- Neuroprotective Effect of Glutathione 2.0 (Deadline: 31 May 2023)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Feature Papers in Molecular Neurobiology
- Neuroimmunology
- Neuroinflammatory Processes in Neurodegenerative Diseases
- Neuroprotective Strategies
- State-of-the-Art Molecular Neurobiology in Germany
- State-of-the-Art Molecular Neurobiology in Italy
- State-of-the-Art Molecular Neurobiology in Japan
- State-of-the-Art Molecular Neurobiology in Korea
- State-of-the-Art Molecular Neurobiology in Poland
- State-of-the-Art Molecular Neurobiology in Russia
- State-of-the-Art Molecular Neurobiology in Spain
- State-of-the-Art Molecular Neurobiology in Switzerland
- State-of-the-Art Molecular Neurobiology in UK
- State-of-the-Art Molecular Neurobiology in USA